カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界のPEG化リン脂質市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global PEGylated Phospholipids Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO4726）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO4726
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のPEG化リン脂質市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

PEG化リン脂質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のPEG化リン脂質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

PEG化リン脂質市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・mPEG-DMPE、mPEG-DSPE、その他

用途別セグメントは次のように区分されます。
・リポソーム封入（LNP）医薬品、その他

世界のPEG化リン脂質市場の主要な市場プレーヤーは以下のとおりです。
・BroadPharm、NOF America、Merck、Jenkem、Avanti Polar Lipids、Lipoid

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、PEG化リン脂質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なPEG化リン脂質メーカーの企業概要、2019年～2022年までのPEG化リン脂質の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なPEG化リン脂質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別PEG化リン脂質の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのPEG化リン脂質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのPEG化リン脂質市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびPEG化リン脂質の産業チェーンを掲載しています。
・第13、14、15章では、PEG化リン脂質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- PEG化リン脂質の概要
- 種類別分析（2017年vs2021年vs2028年）：mPEG-DMPE、mPEG-DSPE、その他
- 用途別分析（2017年vs2021年vs2028年）：リポソーム封入（LNP）医薬品、その他
- 世界のPEG化リン脂質市場規模・予測
- 世界のPEG化リン脂質生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- BroadPharm、NOF America、Merck、Jenkem、Avanti Polar Lipids、Lipoid
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：mPEG-DMPE、mPEG-DSPE、その他
・用途別分析2017年-2028年：リポソーム封入（LNP）医薬品、その他
・PEG化リン脂質の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・PEG化リン脂質のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・PEG化リン脂質のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・PEG化リン脂質の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・PEG化リン脂質の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The PEGylated Phospholipids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PEGylated Phospholipids market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Liposome Encapsulated (LNP) Drugs accounting for % of the PEGylated Phospholipids global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While mPEG-DMPE segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PEGylated Phospholipids include BroadPharm, NOF America, Merck, Jenkem, and Avanti Polar Lipids, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PEGylated Phospholipids market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
mPEG-DMPE
mPEG-DSPE
Other
Market segment by Application can be divided into
Liposome Encapsulated (LNP) Drugs
Other
The key market players for global PEGylated Phospholipids market are listed below:
BroadPharm
NOF America
Merck
Jenkem
Avanti Polar Lipids
Lipoid
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PEGylated Phospholipids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PEGylated Phospholipids, with price, sales, revenue and global market share of PEGylated Phospholipids from 2019 to 2022.
Chapter 3, the PEGylated Phospholipids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PEGylated Phospholipids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PEGylated Phospholipids market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PEGylated Phospholipids.
Chapter 13, 14, and 15, to describe PEGylated Phospholipids sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 PEGylated Phospholipids Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PEGylated Phospholipids Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 mPEG-DMPE
1.2.3 mPEG-DSPE
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global PEGylated Phospholipids Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Liposome Encapsulated (LNP) Drugs
1.3.3 Other
1.4 Global PEGylated Phospholipids Market Size & Forecast
1.4.1 Global PEGylated Phospholipids Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PEGylated Phospholipids Sales in Volume (2017-2028)
1.4.3 Global PEGylated Phospholipids Price (2017-2028)
1.5 Global PEGylated Phospholipids Production Capacity Analysis
1.5.1 Global PEGylated Phospholipids Total Production Capacity (2017-2028)
1.5.2 Global PEGylated Phospholipids Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PEGylated Phospholipids Market Drivers
1.6.2 PEGylated Phospholipids Market Restraints
1.6.3 PEGylated Phospholipids Trends Analysis
2 Manufacturers Profiles
2.1 BroadPharm
2.1.1 BroadPharm Details
2.1.2 BroadPharm Major Business
2.1.3 BroadPharm PEGylated Phospholipids Product and Services
2.1.4 BroadPharm PEGylated Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NOF America
2.2.1 NOF America Details
2.2.2 NOF America Major Business
2.2.3 NOF America PEGylated Phospholipids Product and Services
2.2.4 NOF America PEGylated Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck PEGylated Phospholipids Product and Services
2.3.4 Merck PEGylated Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Jenkem
2.4.1 Jenkem Details
2.4.2 Jenkem Major Business
2.4.3 Jenkem PEGylated Phospholipids Product and Services
2.4.4 Jenkem PEGylated Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Avanti Polar Lipids
2.5.1 Avanti Polar Lipids Details
2.5.2 Avanti Polar Lipids Major Business
2.5.3 Avanti Polar Lipids PEGylated Phospholipids Product and Services
2.5.4 Avanti Polar Lipids PEGylated Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lipoid
2.6.1 Lipoid Details
2.6.2 Lipoid Major Business
2.6.3 Lipoid PEGylated Phospholipids Product and Services
2.6.4 Lipoid PEGylated Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PEGylated Phospholipids Breakdown Data by Manufacturer
3.1 Global PEGylated Phospholipids Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PEGylated Phospholipids Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PEGylated Phospholipids
3.4 Market Concentration Rate
3.4.1 Top 3 PEGylated Phospholipids Manufacturer Market Share in 2021
3.4.2 Top 6 PEGylated Phospholipids Manufacturer Market Share in 2021
3.5 Global PEGylated Phospholipids Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PEGylated Phospholipids Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PEGylated Phospholipids Market Size by Region
4.1.1 Global PEGylated Phospholipids Sales in Volume by Region (2017-2028)
4.1.2 Global PEGylated Phospholipids Revenue by Region (2017-2028)
4.2 North America PEGylated Phospholipids Revenue (2017-2028)
4.3 Europe PEGylated Phospholipids Revenue (2017-2028)
4.4 Asia-Pacific PEGylated Phospholipids Revenue (2017-2028)
4.5 South America PEGylated Phospholipids Revenue (2017-2028)
4.6 Middle East and Africa PEGylated Phospholipids Revenue (2017-2028)
5 Market Segment by Type
5.1 Global PEGylated Phospholipids Sales in Volume by Type (2017-2028)
5.2 Global PEGylated Phospholipids Revenue by Type (2017-2028)
5.3 Global PEGylated Phospholipids Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global PEGylated Phospholipids Sales in Volume by Application (2017-2028)
6.2 Global PEGylated Phospholipids Revenue by Application (2017-2028)
6.3 Global PEGylated Phospholipids Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America PEGylated Phospholipids Sales by Type (2017-2028)
7.2 North America PEGylated Phospholipids Sales by Application (2017-2028)
7.3 North America PEGylated Phospholipids Market Size by Country
7.3.1 North America PEGylated Phospholipids Sales in Volume by Country (2017-2028)
7.3.2 North America PEGylated Phospholipids Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe PEGylated Phospholipids Sales by Type (2017-2028)
8.2 Europe PEGylated Phospholipids Sales by Application (2017-2028)
8.3 Europe PEGylated Phospholipids Market Size by Country
8.3.1 Europe PEGylated Phospholipids Sales in Volume by Country (2017-2028)
8.3.2 Europe PEGylated Phospholipids Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific PEGylated Phospholipids Sales by Type (2017-2028)
9.2 Asia-Pacific PEGylated Phospholipids Sales by Application (2017-2028)
9.3 Asia-Pacific PEGylated Phospholipids Market Size by Region
9.3.1 Asia-Pacific PEGylated Phospholipids Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PEGylated Phospholipids Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America PEGylated Phospholipids Sales by Type (2017-2028)
10.2 South America PEGylated Phospholipids Sales by Application (2017-2028)
10.3 South America PEGylated Phospholipids Market Size by Country
10.3.1 South America PEGylated Phospholipids Sales in Volume by Country (2017-2028)
10.3.2 South America PEGylated Phospholipids Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PEGylated Phospholipids Sales by Type (2017-2028)
11.2 Middle East & Africa PEGylated Phospholipids Sales by Application (2017-2028)
11.3 Middle East & Africa PEGylated Phospholipids Market Size by Country
11.3.1 Middle East & Africa PEGylated Phospholipids Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PEGylated Phospholipids Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of PEGylated Phospholipids and Key Manufacturers
12.2 Manufacturing Costs Percentage of PEGylated Phospholipids
12.3 PEGylated Phospholipids Production Process
12.4 PEGylated Phospholipids Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PEGylated Phospholipids Typical Distributors
13.3 PEGylated Phospholipids Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global PEGylated Phospholipids Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global PEGylated Phospholipids Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. BroadPharm Basic Information, Manufacturing Base and Competitors
Table 4. BroadPharm Major Business
Table 5. BroadPharm PEGylated Phospholipids Product and Services
Table 6. BroadPharm PEGylated Phospholipids Sales (Tons), Price (US$/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. NOF America Basic Information, Manufacturing Base and Competitors
Table 8. NOF America Major Business
Table 9. NOF America PEGylated Phospholipids Product and Services
Table 10. NOF America PEGylated Phospholipids Sales (Tons), Price (US$/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck PEGylated Phospholipids Product and Services
Table 14. Merck PEGylated Phospholipids Sales (Tons), Price (US$/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Jenkem Basic Information, Manufacturing Base and Competitors
Table 16. Jenkem Major Business
Table 17. Jenkem PEGylated Phospholipids Product and Services
Table 18. Jenkem PEGylated Phospholipids Sales (Tons), Price (US$/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table 20. Avanti Polar Lipids Major Business
Table 21. Avanti Polar Lipids PEGylated Phospholipids Product and Services
Table 22. Avanti Polar Lipids PEGylated Phospholipids Sales (Tons), Price (US$/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Lipoid Basic Information, Manufacturing Base and Competitors
Table 24. Lipoid Major Business
Table 25. Lipoid PEGylated Phospholipids Product and Services
Table 26. Lipoid PEGylated Phospholipids Sales (Tons), Price (US$/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global PEGylated Phospholipids Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 28. Global PEGylated Phospholipids Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in PEGylated Phospholipids, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global PEGylated Phospholipids Production Capacity by Company, (Tons): 2020 VS 2021
Table 31. Head Office and PEGylated Phospholipids Production Site of Key Manufacturer
Table 32. PEGylated Phospholipids New Entrant and Capacity Expansion Plans
Table 33. PEGylated Phospholipids Mergers & Acquisitions in the Past Five Years
Table 34. Global PEGylated Phospholipids Sales by Region (2017-2022) & (Tons)
Table 35. Global PEGylated Phospholipids Sales by Region (2023-2028) & (Tons)
Table 36. Global PEGylated Phospholipids Revenue by Region (2017-2022) & (USD Million)
Table 37. Global PEGylated Phospholipids Revenue by Region (2023-2028) & (USD Million)
Table 38. Global PEGylated Phospholipids Sales by Type (2017-2022) & (Tons)
Table 39. Global PEGylated Phospholipids Sales by Type (2023-2028) & (Tons)
Table 40. Global PEGylated Phospholipids Revenue by Type (2017-2022) & (USD Million)
Table 41. Global PEGylated Phospholipids Revenue by Type (2023-2028) & (USD Million)
Table 42. Global PEGylated Phospholipids Price by Type (2017-2022) & (US$/KG)
Table 43. Global PEGylated Phospholipids Price by Type (2023-2028) & (US$/KG)
Table 44. Global PEGylated Phospholipids Sales by Application (2017-2022) & (Tons)
Table 45. Global PEGylated Phospholipids Sales by Application (2023-2028) & (Tons)
Table 46. Global PEGylated Phospholipids Revenue by Application (2017-2022) & (USD Million)
Table 47. Global PEGylated Phospholipids Revenue by Application (2023-2028) & (USD Million)
Table 48. Global PEGylated Phospholipids Price by Application (2017-2022) & (US$/KG)
Table 49. Global PEGylated Phospholipids Price by Application (2023-2028) & (US$/KG)
Table 50. North America PEGylated Phospholipids Sales by Country (2017-2022) & (Tons)
Table 51. North America PEGylated Phospholipids Sales by Country (2023-2028) & (Tons)
Table 52. North America PEGylated Phospholipids Revenue by Country (2017-2022) & (USD Million)
Table 53. North America PEGylated Phospholipids Revenue by Country (2023-2028) & (USD Million)
Table 54. North America PEGylated Phospholipids Sales by Type (2017-2022) & (Tons)
Table 55. North America PEGylated Phospholipids Sales by Type (2023-2028) & (Tons)
Table 56. North America PEGylated Phospholipids Sales by Application (2017-2022) & (Tons)
Table 57. North America PEGylated Phospholipids Sales by Application (2023-2028) & (Tons)
Table 58. Europe PEGylated Phospholipids Sales by Country (2017-2022) & (Tons)
Table 59. Europe PEGylated Phospholipids Sales by Country (2023-2028) & (Tons)
Table 60. Europe PEGylated Phospholipids Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe PEGylated Phospholipids Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe PEGylated Phospholipids Sales by Type (2017-2022) & (Tons)
Table 63. Europe PEGylated Phospholipids Sales by Type (2023-2028) & (Tons)
Table 64. Europe PEGylated Phospholipids Sales by Application (2017-2022) & (Tons)
Table 65. Europe PEGylated Phospholipids Sales by Application (2023-2028) & (Tons)
Table 66. Asia-Pacific PEGylated Phospholipids Sales by Region (2017-2022) & (Tons)
Table 67. Asia-Pacific PEGylated Phospholipids Sales by Region (2023-2028) & (Tons)
Table 68. Asia-Pacific PEGylated Phospholipids Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific PEGylated Phospholipids Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific PEGylated Phospholipids Sales by Type (2017-2022) & (Tons)
Table 71. Asia-Pacific PEGylated Phospholipids Sales by Type (2023-2028) & (Tons)
Table 72. Asia-Pacific PEGylated Phospholipids Sales by Application (2017-2022) & (Tons)
Table 73. Asia-Pacific PEGylated Phospholipids Sales by Application (2023-2028) & (Tons)
Table 74. South America PEGylated Phospholipids Sales by Country (2017-2022) & (Tons)
Table 75. South America PEGylated Phospholipids Sales by Country (2023-2028) & (Tons)
Table 76. South America PEGylated Phospholipids Revenue by Country (2017-2022) & (USD Million)
Table 77. South America PEGylated Phospholipids Revenue by Country (2023-2028) & (USD Million)
Table 78. South America PEGylated Phospholipids Sales by Type (2017-2022) & (Tons)
Table 79. South America PEGylated Phospholipids Sales by Type (2023-2028) & (Tons)
Table 80. South America PEGylated Phospholipids Sales by Application (2017-2022) & (Tons)
Table 81. South America PEGylated Phospholipids Sales by Application (2023-2028) & (Tons)
Table 82. Middle East & Africa PEGylated Phospholipids Sales by Region (2017-2022) & (Tons)
Table 83. Middle East & Africa PEGylated Phospholipids Sales by Region (2023-2028) & (Tons)
Table 84. Middle East & Africa PEGylated Phospholipids Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa PEGylated Phospholipids Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa PEGylated Phospholipids Sales by Type (2017-2022) & (Tons)
Table 87. Middle East & Africa PEGylated Phospholipids Sales by Type (2023-2028) & (Tons)
Table 88. Middle East & Africa PEGylated Phospholipids Sales by Application (2017-2022) & (Tons)
Table 89. Middle East & Africa PEGylated Phospholipids Sales by Application (2023-2028) & (Tons)
Table 90. PEGylated Phospholipids Raw Material
Table 91. Key Manufacturers of PEGylated Phospholipids Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. PEGylated Phospholipids Typical Distributors
Table 95. PEGylated Phospholipids Typical Customers
List of Figures
Figure 1. PEGylated Phospholipids Picture
Figure 2. Global PEGylated Phospholipids Revenue Market Share by Type in 2021
Figure 3. mPEG-DMPE
Figure 4. mPEG-DSPE
Figure 5. Other
Figure 6. Global PEGylated Phospholipids Revenue Market Share by Application in 2021
Figure 7. Liposome Encapsulated (LNP) Drugs
Figure 8. Other
Figure 9. Global PEGylated Phospholipids Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 10. Global PEGylated Phospholipids Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global PEGylated Phospholipids Sales (2017-2028) & (Tons)
Figure 12. Global PEGylated Phospholipids Price (2017-2028) & (US$/KG)
Figure 13. Global PEGylated Phospholipids Production Capacity (2017-2028) & (Tons)
Figure 14. Global PEGylated Phospholipids Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. PEGylated Phospholipids Market Drivers
Figure 16. PEGylated Phospholipids Market Restraints
Figure 17. PEGylated Phospholipids Market Trends
Figure 18. Global PEGylated Phospholipids Sales Market Share by Manufacturer in 2021
Figure 19. Global PEGylated Phospholipids Revenue Market Share by Manufacturer in 2021
Figure 20. PEGylated Phospholipids Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 PEGylated Phospholipids Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 PEGylated Phospholipids Manufacturer (Revenue) Market Share in 2021
Figure 23. Global PEGylated Phospholipids Sales Market Share by Region (2017-2028)
Figure 24. Global PEGylated Phospholipids Revenue Market Share by Region (2017-2028)
Figure 25. North America PEGylated Phospholipids Revenue (2017-2028) & (USD Million)
Figure 26. Europe PEGylated Phospholipids Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific PEGylated Phospholipids Revenue (2017-2028) & (USD Million)
Figure 28. South America PEGylated Phospholipids Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa PEGylated Phospholipids Revenue (2017-2028) & (USD Million)
Figure 30. Global PEGylated Phospholipids Sales Market Share by Type (2017-2028)
Figure 31. Global PEGylated Phospholipids Revenue Market Share by Type (2017-2028)
Figure 32. Global PEGylated Phospholipids Price by Type (2017-2028) & (US$/KG)
Figure 33. Global PEGylated Phospholipids Sales Market Share by Application (2017-2028)
Figure 34. Global PEGylated Phospholipids Revenue Market Share by Application (2017-2028)
Figure 35. Global PEGylated Phospholipids Price by Application (2017-2028) & (US$/KG)
Figure 36. North America PEGylated Phospholipids Sales Market Share by Type (2017-2028)
Figure 37. North America PEGylated Phospholipids Sales Market Share by Application (2017-2028)
Figure 38. North America PEGylated Phospholipids Sales Market Share by Country (2017-2028)
Figure 39. North America PEGylated Phospholipids Revenue Market Share by Country (2017-2028)
Figure 40. United States PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe PEGylated Phospholipids Sales Market Share by Type (2017-2028)
Figure 44. Europe PEGylated Phospholipids Sales Market Share by Application (2017-2028)
Figure 45. Europe PEGylated Phospholipids Sales Market Share by Country (2017-2028)
Figure 46. Europe PEGylated Phospholipids Revenue Market Share by Country (2017-2028)
Figure 47. Germany PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific PEGylated Phospholipids Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific PEGylated Phospholipids Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific PEGylated Phospholipids Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific PEGylated Phospholipids Revenue Market Share by Region (2017-2028)
Figure 56. China PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America PEGylated Phospholipids Sales Market Share by Type (2017-2028)
Figure 63. South America PEGylated Phospholipids Sales Market Share by Application (2017-2028)
Figure 64. South America PEGylated Phospholipids Sales Market Share by Country (2017-2028)
Figure 65. South America PEGylated Phospholipids Revenue Market Share by Country (2017-2028)
Figure 66. Brazil PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa PEGylated Phospholipids Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa PEGylated Phospholipids Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa PEGylated Phospholipids Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa PEGylated Phospholipids Revenue Market Share by Region (2017-2028)
Figure 72. Turkey PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa PEGylated Phospholipids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of PEGylated Phospholipids in 2021
Figure 77. Manufacturing Process Analysis of PEGylated Phospholipids
Figure 78. PEGylated Phospholipids Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のペグ化脂質市場2022年：市場規模予測（～2028年）
  • 世界のペグ化リポソームドコルビシン市場2022年：市場規模予測（～2028年）
  • 世界の弾道繊維素材市場2022年：市場規模予測（～2028年）
  • 世界の農業用キトサン市場2022年：市場規模予測（～2028年）
  • 世界のトリス（2,2,6,6-テトラメチル-3,5-ヘプタンジオナト）チタン（III）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO4726 )"世界のPEG化リン脂質市場2022年：市場規模予測（～2028年）" (英文：Global PEGylated Phospholipids Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。